SnapshotNIR featured in interview with Dr. Windy Cole on the Wound Care Learning Network

Curious how SnapshotNIR fits the theragnostic definition? Or how SnapshotNIR can be used as a non-invasive vascular assessment to improve delivery of quality care? Or how this new and novel technology is being used in clinical research and private practice? The Wound Care Learning Network chatted with Dr. Windy Cole, DPM, Adjunct Professor and Director of Wound Care Research at Kent State University College of Podiatric Medicine, to answer these questions based on her experience using the device.

For answers, watch the video spotlight on SnapshotNIR here.


SnapshotNIR Used to Identify Patterns of StO2 in Wound Healing

In a retrospective study published in Wounds (October 2020), Adam Landsman, DPM, PHD, set out to identify if distinct patterns of tissue oxygen saturation (StO2) in the wound and periwound tissues are associated with wound healing. Using near infrared spectroscopy (NIRS), 25 patients with diabetic foot ulcers or venous leg ulcers were imaged throughout their course of therapy. Retrospectively, the images were analzed for common patterns in StO2 that may predict whether or not a wound would heal.

Read the full article, Visualization of Wound Healing Progression with Near Infrared Spectroscopy: A Retrospective Study, to learn more about Dr. Landsman’s findings, including the four stages identified as H.I.N.T.


Kent Imaging and SerenaGroup® Research Foundation awarded prestigious AICE grant

September 22, 2020. Kent Imaging and SerenaGroup® Research Foundation, have received the prestigious Accelerating Innovations into Care (AICE)Market Access grant from Alberta Innovates, a research and innovation agency sponsored by the province of Alberta, Canada. AICE supports companies in commercializing innovative digital health technologies. The award will fund clinical trials investigating the novel diagnostic technology developed by Kent Imaging utilizing near infrared spectroscopy (SnapshotNIR). Kent has partnered with SerenaGroup® Research Foundation to conduct this pivotal research.

Near infrared spectroscopy measures oxygen levels in tissue in real time without the need for injected dyes or invasive probes.  SnapshotNIR captures the image without patient contact. The colors displayed on the screen correspond to the degree of tissue oxygenation:  blue represents low oxygen levels and red represents high.  At present, advanced wound and hyperbaric centers use transcutaneous oxygen (TCOM) to measure oxygenation; however, TCOM has numerous drawbacks: the results are operator dependent, it requires heated leads that are attached to the skin and the procedure takes an hour to complete.

The AICE grant will fund a multicenter head-to-head clinical trial comparing SnapshotNIR to TCOM. In addition, correlation between the SnapshotNIR readings and healing outcomes will allow the investigators to predict the best interventions for patients with diminished oxygenation. “Health innovators often face headwinds in generating the evidence necessary for implementing new solutions. The data generated in this trial will accelerate the path to impact for SnapshotNIR, and is fully aligned with our digital health strategy,” shared Tim Murphy, VP Health at Alberta Innovates.

“This new technology from Kent Imaging will allow clinicians to rapidly assess tissue oxygenation in patients with chronic wounds, which will avoid delays in diagnosis and treatment,” said Dr. Tomas Serena, Director of the SerenaGroup® Research Foundation. “I believe that SnapshotNIR will play a key role in limb preservation in our diabetic patients, allowing woundologists to identify the patients who will benefit from advanced modalities such as for hyperbaric oxygen therapy.”

“We are very excited to be working with Dr. Tomas Serena and the SerenaGroup® Research Foundation to establish definitively the value of SnapshotNIR in the prediction of wound healing. Kent Imaging’s goal is to provide innovative technology that helps physicians to heal wounds, improve outcomes and significantly reduce amputations. This study will take us a long way towards meeting this goal,” said Pierre Lemire, CEO at Kent Imaging. “We also want to acknowledge the ongoing support of the Alberta Government in bringing this paradigm changing technology to market.”

About Kent Imaging

Kent Imaging Inc., a Canadian company located in Calgary, Alberta, and leading innovator in oxygenation imaging, designs and manufactures imaging technology that employs near infrared spectroscopy to measure tissue oxygen saturation. The oxygenation information provides immediate insight into tissue viability supporting real-time decision making in wound care, vascular and surgical specialties to aid in the delivery of positive patient outcomes throughout the care continuum.  For more information about Kent Imaging, visit www.kentimaging.com.

About SerenaGroup® Research Foundation

The SerenaGroup® Research Foundation, a leader in wound healing research, conducts eight to nine clinical trials each year and publishes a dozen manuscripts annually. Dr. Serena has been the lead or Principal Investigator in over 100 clinical trials, including gene therapy, dressings, growth factors, topical and parenteral antibiotics, and CTP therapy.  His team has led the development of diagnostic imaging and biomarkers in the field of wound healing.  

About Alberta Innovates

Alberta Innovates invests in research, innovation and entrepreneurship to drive provincial economic growth and diversity. We ignite the power of innovation through our work with researchers, industry and entrepreneurs to move Alberta to a lower-carbon future, enhance the responsible use of land and water, and contribute to the improved health and well-being of Albertans.

New and novel methods of non-invasive vascular assessment: enhancing triage protocols in wound healing and limb salvage

This CE/CME/CECH webinar presented by Dr. Richard Neville, MD (Director, Inova Vascular) and moderated by Dr. Lee Rogers, DPM (Chief Medical Officer at Amputation Prevention Experts (APEx) Health Network), is supported through an unrestricted educational grant from Kent Imaging. A recording of the webinar will reside on the podiatry.com website for 12 months following the live event. Register now for what is sure to be an intriguing topic in the management of critical limb ischemia.

Supporting Wound Care Services through Remote Diagnostic Imaging

I hope that you continue to stay safe in this challenging environment, while you strive to provide on-going care for your wound patients.  We appreciate that these are unprecedented times, and Kent Imaging is focused on supporting you and your patients through the “new normal” which is anything but.

We understand that proper wound care is essential to preserving tissue and limbs and that “time is tissue.” We’re seeing proactive clinics adopting telehealth and remote diagnostic technologies to assist with wound triage to ensure patients are effectively prioritized for inpatient care.

In order to assist with this transition, Kent Imaging has refocused its resources to meet the demand from existing SnapshotNIR customers to release an update that remotely provides an informative assessment of the wound and vascular status.  Our partners have been instrumental in the development of this solution and continue to determine the best way SnapshotNIR can help them keep their patients out of the hospitals.

By embracing new methods of care including remote diagnostics to support triage decisions, providers can better understand wound progression remotely, providing appropriate referrals to those who need them, and protecting the health of patients who are unable to come to the hospital or are at high risk for COVID-19.

Please don’t hesitate to contact Kent Imaging to learn more. We have set-up a support center to provide online access to technical and clinical expertise to assist your staff with remote deployment and image assessment.

Your sincerely,

This image has an empty alt attribute; its file name is Pierre-Lemire-Signature1945.png

Pierre Lemire

CEO, Kent Imaging

pierre@kentimaging.com